Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Selexis sure-technology platform™.
View:
Post by Mole101 on May 21, 2021 9:42am

Selexis sure-technology platform™.

 
With the accelerated RCB program Selexis can move from transfection to the transfer of
a high-expressing and stable production-ready research cell bank in 14 weeks, a process that often takes other companies 8–12 months.
Safety
Comment by BottomBroker on May 21, 2021 10:01am
I like it. Looks like PMN wants to get things going as quickly as possible. 
Comment by Speyeder999 on May 21, 2021 10:31am
Fantastic news....Possible dbut of clinical trials this fall?
Comment by retiredcop on May 21, 2021 10:40am
I wouldn't crack the champagne quite yet....when we see the official.notice of intent to conduct clinicals to hc and FDA or.eu authorities...that's when you know it's happening...I think.these drugs wont be ready for.at least 6 months..but I stand to.be corrected
Comment by BottomBroker on May 21, 2021 11:20am
True, but after literally years of nothing, it's nice to see some progress. Or at least the intent to make some progress. 
Comment by Mole101 on May 21, 2021 11:26am
You're  right with that assessment, it's been a long quite road ...I'm looking forward to see where they go with their ALS program, I think it's likely We will get some news on direction soon..  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities